Tailor-made Pharma Solutions l Pharma Intelligence

Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Conferences 2021

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Pink Sheet

Download your free accelerated trials article pack for insights into the latest developments

07 Dec 2021

Don’t miss updates on recent news in accelerated trials and its implications for drug development in the United States.

Topic Business Strategies

View article
Citeline Connect

Connect the dots between patients and clinical trials

06 Dec 2021

Accelerate study startup, drive engagement, and enable community and communication surrounding your clinical trials with Citeline Connect, the only end-to-end platform supporting all aspects of clinical trial recruitment.

Topic Business Strategies Clinical Trials

View white paper
What Does The Pharma Industry Want From CROs?

02 Dec 2021

Get exclusive insights into what senior decision makers from small to large biotech and pharma companies want from contract research organizations.

Market Intelligence Business Strategies Leadership

View infographic
Generics Bulletin

Bio-Thera’s Bevacizumab US Action Date Passes Without Approval

By David Wallace 01 Dec 2021

Bio-Thera Solutions had been hoping to become the first Chinese biosimilars developer to win an FDA approval, for its BAT1706 bevacizumab candidate. However, the announced FDA action date for the application has come and gone with no word from the company or regulator.

View article
Pink Sheet

Divided US FDA AdComm Backs Molnupiravir Authorization But Wants More Studies

By Brenda Sandburg 01 Dec 2021

In 13-10 vote, panel finds reduction in COVID-19 hospitalizations and deaths outweighs risks. Four members say FDA should reconsider authorization if a more effective and safer therapy comes along. They concur molnupiravir should not be recommended for use in pregnancy but available to those who want it.

View article
Scrip

APAC Podcast: Policies Play Out Against Pandemic, Corporate Activity Remains Strong

By Ian Haydock 01 Dec 2021

Join the Asia Pacific content team for a wide-ranging overview and analysis of recent developments across China, India, South Korea and Japan in the policy, regulatory, commercial and vaccines spaces over the past few months.

View article
Pharma Intelligence Apps

Not all news services are created equal

30 Nov 2021

Pharma Insights team of trusted journalists bring you the most critical news and analysis round the clock. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.

Single report
Generics Bulletin

ANI Pharmaceuticals Completes $210m Novitium Acquisition

By Chloe Kent 30 Nov 2021

ANI Pharmaceuticals has completed its acquisition of niche generics specialist Novitium Pharma, securing access to a pipeline of generics and 505(b)(2) candidates that has expanded further since the deal was announced earlier in the year.

View article
Medtech Insight

US FDA-Sponsored Cybersecurity Threat Modeling Playbook Tries To Make It Simple

By Ferdous Al-Faruque 30 Nov 2021

The MITRE corporation and MDIC have produced a manual on how to use cybersecurity threat modeling to make safer medical devices. The document asks four basic questions and provides helpful examples.

View article
Medtech Insight

Exec Chat: CMR Surgical Prepares For Intensifying Competition In RAS

By Barnaby Pickering 30 Nov 2021

In an interview with Medtech Insight, Per Vegard Nerserth, CEO of CMR Surgical, discusses how the company adapted to the pandemic, its future plans, and how the competition for market dominance is shaping up.

View article
Scrip

COVID-19 Vaccine Makers Pledge Rapid Response To Omicron Threat

By Andrew McConaghie 29 Nov 2021

While news of a potentially highly transmissible new variant is causing alarm, Pfizer/BioNTech and Moderna are already pursuing a multi-pronged response to B.1.1.529.

View article
Scrip

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 28 Nov 2021

In this week's podcast edition of Five Must-Know Things: the prospects and plans for J&J’s pharma and oncology business; China looks more inward under new policies; an important US approval for Takeda; and Moderna’s co-founder shares tips on innovation.

View article
Scrip

Finance Watch: Venture Capital Drives Record-Breaking Year For Cell And Gene Therapies

By Mandy Jackson 25 Nov 2021

Private Company Edition: Recent VC financings across biopharma sectors include three major mega-rounds as Generate Biomedicines bringing in $370m, followed by $250m for Acelyrin and $125m for Chroma Medicine. Also, Treadwell raised a $91m series B and Ncardia brought in $60m-plus.

View article
Scrip

Moderna Co-Founder Robert Langer’s Tips For Innovation

By Vibha Ravi 22 Nov 2021

Moderna co-founder Robert Langer shared tips to drive innovation at a recent summit, while narrating a fascinating tale of tenacity during the development of angiogenesis inhibitors with Judah Folkman. If an idea is important, it’s sure to be criticized, said the man who has over 1,000 patents issued or pending worldwide.

View article
In Vivo

How Will Pfizer Leverage External Innovation After BioNTech Jackpot?

By Lucie Ellis-Taitt 22 Nov 2021

Uwe Schoenbeck, CSO of external science and innovation at Pfizer, knows the company set itself a high bar during the COVID-19 pandemic after rapidly bringing a breakthrough vaccine to market. While the circumstances for the development of Comirnaty were truly unique, Pfizer does not expect to rest on its laurels when it comes to innovative R&D.

View article

Latest headlines

Medtech Insight

09 Dec 2021

The Top 10 Medtech Themes For 2022 – And M&A Trends

Link
HBW Insight

09 Dec 2021

Global Beauty And Personal Care Growth Unleashed Despite Market Tensions In Changed World

Link
Scrip

08 Dec 2021

BeiGene Switches To Combo Therapy Approach For Brukinsa

Link
Scrip

08 Dec 2021

Mutation Quirk In NRx’s COVID-19 Vaccine Asset Could Help Fights VOCs

Link
Pink Sheet

08 Dec 2021

Reata’s Bardoxolone Shot Down, But US FDA Advisors Offers Suggestions For Improved Study

Link
Scrip

08 Dec 2021

Roche And Recursion’s AI Drug Discovery Pact To Focus On Neuroscience

Link
In Vivo

08 Dec 2021

Inside Sanofi’s General Medicines Unit: Embracing A New Commercial Model

Link
In Vivo

08 Dec 2021

Execs On The Move, November 2021

Link
In Vivo

08 Dec 2021

COVID-19 R&D: Pharma’s Path Ahead

Link
Pink Sheet

08 Dec 2021

EU Bodies Back Mix-And-Match Approach For COVID-19 Boosters

Link
Generics Bulletin

08 Dec 2021

Prestige Plans ‘Strong Price Competitiveness’ For Its Adalimumab Biosimilar

Link
Pink Sheet

08 Dec 2021

Rare Chance Or Passing Opportunity: China Expands Orphan Drug Coverage With Steep Price Cuts

Link
Pink Sheet

08 Dec 2021

President Biden And Drug Prices: Why Does No One Seem To Care?

Link
Medtech Insight

08 Dec 2021

COVID-19 Omicron Variant Could Cause False-Negative Results In Tide Labs Test, FDA Says

Link
Pink Sheet

08 Dec 2021

Will FTC Injunction Against Shkreli’s Company Deter Brands From Pursuing Anti-Generic Actions?

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Speak to Sales

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact Sales

Client Services

US Toll-Free : +1 888 670 8900
US Toll : +1 212-600-3520
UK & Europe : +44 (0) 208 052 0700

Contact Customer Services

Pharma Report Store

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

Download your free accelerated trials article pack for insights into the latest developments

Connect the dots between patients and clinical trials

What Does The Pharma Industry Want From CROs?

Bio-Thera’s Bevacizumab US Action Date Passes Without Approval

Divided US FDA AdComm Backs Molnupiravir Authorization But Wants More Studies

APAC Podcast: Policies Play Out Against Pandemic, Corporate Activity Remains Strong

Not all news services are created equal

ANI Pharmaceuticals Completes $210m Novitium Acquisition

US FDA-Sponsored Cybersecurity Threat Modeling Playbook Tries To Make It Simple

Exec Chat: CMR Surgical Prepares For Intensifying Competition In RAS

COVID-19 Vaccine Makers Pledge Rapid Response To Omicron Threat

Quick Listen: Scrip's Five Must-Know Things

Finance Watch: Venture Capital Drives Record-Breaking Year For Cell And Gene Therapies

Moderna Co-Founder Robert Langer’s Tips For Innovation

How Will Pfizer Leverage External Innovation After BioNTech Jackpot?

Latest headlines

The Top 10 Medtech Themes For 2022 – And M&A Trends

Global Beauty And Personal Care Growth Unleashed Despite Market Tensions In Changed World

BeiGene Switches To Combo Therapy Approach For Brukinsa

Mutation Quirk In NRx’s COVID-19 Vaccine Asset Could Help Fights VOCs

Reata’s Bardoxolone Shot Down, But US FDA Advisors Offers Suggestions For Improved Study

Roche And Recursion’s AI Drug Discovery Pact To Focus On Neuroscience

Inside Sanofi’s General Medicines Unit: Embracing A New Commercial Model

Execs On The Move, November 2021

COVID-19 R&D: Pharma’s Path Ahead

EU Bodies Back Mix-And-Match Approach For COVID-19 Boosters

Prestige Plans ‘Strong Price Competitiveness’ For Its Adalimumab Biosimilar

Rare Chance Or Passing Opportunity: China Expands Orphan Drug Coverage With Steep Price Cuts

President Biden And Drug Prices: Why Does No One Seem To Care?

COVID-19 Omicron Variant Could Cause False-Negative Results In Tide Labs Test, FDA Says

Will FTC Injunction Against Shkreli’s Company Deter Brands From Pursuing Anti-Generic Actions?

Next steps

This is Contactus Section

Request a live demo

Speak to Sales

Client Services

Pharma Report Store